ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 14 of 61
УЖМБС 2018, 3(5): 72–76
Clinical Medicine

Features of Skin Care for Patients with Rosacea in Different Periods of the Disease

Vasylenko A. V.

According to the literature of recent years, it is known that rosacea is a topical medical and social problem due to the widespread morbidity and frequent recurrence of the disease. There remain unresolved questions regarding aetiology, some aspects of pathogenesis, treatment of this dermatosis and, especially, preventive measures. There is no research on the features of the clinic and the course of recurrence of rosacea. The article presents modern data on the complex study of the clinical features of various clinical forms and periods of rosacea and the development of modern skin care methods in the interdivision period for qualitative prolongation of remission. Material and methods. 80 patients with rosacea were studied. There were 54 women (67.5%) and 26 men (32.5%) among them. Moreover, 20 patients were with the first identified rosacea and 60 patients with relapses of rosacea. The control group consisted of 20 persons of practically healthy patients. Results and discussion. During the treatment, the clinical manifestations of the disease were assessed, and the DLQI index was determined on the ball scales. In a comparative analysis of data on anamnesis and clinical manifestations, it was found out that certain features were identified in patients with recurrent rosacea. Thus, in 5 out of 20 patients (25%) with the newly discovered rosacea and in 52 of 60 patients (86.6%) with recurrent rosacea, there were subjective complaints (itching, burning and tingling, stinging, dry skin with peeling, feeling tides to the face, swelling of the face, feeling of crawling ants, and numbness), which, in turn, caused more significant psycho-emotional disorders. Patients with rosacea, who were examined both in the primary, and in the comparison groups, taking into account the generally accepted recommendations, received a standard therapy in the period of exacerbation of the disease. We have developed a scientifically based method for the comprehensive treatment of patients with relapses of rosacea in the acute period. The features of this method are the additional use of drugs that affect most pathogenesis factors and aimed at eliminating all identified pathogenetic disorders and in the complex have a stronger effect on the stabilization of the whole organism as a whole. In order to prevent the development of recurrences of rosacea, it was also recommended to use special medical care products for care. Thus, patients after the course of basic therapy passed to special medical care for sensitive, prone to reddening of the skin. The revealed changes indicated that recurrences of rosacea proceed more malignant, have a more severe course and their peculiarities. The data of the study showed the importance of early detection of pathogenic and clinical changes to correct a comprehensive selection of differentiated treatment in the acute phase and special cosmetics for skin in remission to prevent relapse of the disease. Conclusions. The results of comparison of the further course and clinical manifestations of dermatosis after the treatment showed the benefit of the effectiveness of the proposed method of complex therapy and prevention of the development of relapses in patients with rosacea. Rational treatment with the subsequent appointment of prophylactic cosmetic skin care is a key factor in preventing the development of relapses of rosacea and confirms the validity and effectiveness of our treatment method, prevention and prediction of relapse.

Keywords: rosacea, relapses, pathogenesis, skin care, quality of life

Full text: PDF (Ukr) 202K

  1. Davydova YB, Chkhatval NA, Koroleva MA. Opyt prymenenyya metronydazola v kompleksnom lechenyy sosudystopy patology kozhy. Klynycheskaya dermatologyya y venerologyya. 2010; 6: 62–4. [Russian]
  2. Dermatovenerologyya: Nats Rukovodstvo. Pod red YuK Skrypkyna, YuS Butova, OL Yvanova. M: GEOTAR-Medya, 2011. 1119 s. [Russian]
  3. Evropeyskoe rukovodstvo po lechenyyu dermatologycheskykh zabolevanyy. Pod red AD Katsambasa, TM Lotty. M: MEDpress-ynform, 2008. 736 s. [Russian]
  4. Kalyuzhna LD, Bardova KO. Mozhlyvosti zastosuvannya preparativ metronidazolu v likuvanni rozatsea ta perioralnogo dermatytu, poyednanykh z demodekozom. Ukr zhurn dermatol, venerol, kosmetol. 2012; 4 (47): 42-6. [Ukrainian]
  5. Katkhanova OA, Levchenko NYu, Anykyenko OV. Etyopatogenetycheskye aspekty rozatsea, vozmozhnosty terapyy. Dalnevostochnyy vestnyk dermatovenerologyy kosmetologyy y plastycheskoy khyrurgyy. 2012; 1: 11-2. [Russian]
  6. Kochergyn NG, Petrunyn DD. Sovremennyy vzglyad na problemu vybora lekarstvennoy formy sredstv naruzhnoy terapyy. Klyn dermatol y venerol. 2012; 1: 33-46. [Russian]
  7. Kuzyna ZA, Danylevskaya RS, Grebennykov VA. K voprosu o terapyy rozatsea. Klynycheskaya dermatologyya y venerologyya. 2011; 2: 60-2. [Russian]
  8. Kutasevych YaF, Mashtakova YA, Oleynyk YA. Mesto systemnykh retynoydov v lechenyy rozatsea. Ukrayinskyy zhurnal dermatologiyi, venerologiyi, kosmetologiyi. 2013; 1 (48): 113-7. [Russian]
  9. Leonova MA. Osobennosty narushenyya tsytokynovoy regulyatsyy u bolnykh rozatsea. Klyn lab dyagnostyka. 2010; 9: 44-64. [Russian]
  10. Olysova OYu. Sovremennye svedenyya o patogeneze rozatsea. Eksperymentalnaya y klynycheskaya dermatokosmetologyya. 2010; 6: 18–22. [Russian]
  11. Pashynyan AG, Shapoval ES, Dzhavaeva DG. Pryntsypy ukhoda za kozhey patsyentov s rozatsea. Vestnyk dermatologyy y venerologyy. 2012; 2: 84–6. [Russian]
  12. Khayrudynov VR. Rozatsea: sovremennye predstavlenyya o patogeneze, klynycheskoy kartyne y lechenyy. Effektyvnaya farmakoterapyya. 2014; 3: 32-7. [Russian]
  13. Casas C, Paul C, Lahfa M. Quantification of Demodex folliculorum by PCR im rosacea and its relationship to skin innate immune activation. Experimental Dermatology. 2012; 21: 901-10.
  14. Chang BP, Kurian A, Barankin B. Rosacea: an update on medical therapies. Skin Therapy Lett. 2014; 3: 1–4.
  15. Eckel R. Rosacea: the strawberry field sof dermatology. Prime Journal. 2014; 4 (4): 30-40.
  16. Van Zuuren EJ, Kramer SF, Carter BR, Graber MA, Fedorowicz Z. Effective and evidence–based management strategies for rosacea: summary of a Cochrane systematic review. Brit J Dermatol. 2011; 165: 760-81.
  17. Tüzün Y, Wolf R, Kutlubay Z, Karakuş O, Engin B. Rosacea and rhinophyma. Clin Dermatol. 2014; 32 (1): 35-46.